Fatty liver frailty: do men and women differ?
NCT ID NCT07652892
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This observational study aims to see if frailty—a state of increased weakness and vulnerability—differs between men and women with MASLD (fatty liver disease). Researchers will track 140 participants over time using physical tests and questionnaires. No drugs or treatments are being tested; the goal is to gather knowledge for better future care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better understand frailty risks in fatty liver patients and tailor care by sex.
- What could go wrong
- This is an observational study, not a treatment trial. It cannot prove cause and effect, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital de la Santa Creu i Sant Pau
NOT_YET_RECRUITINGBarcelona, Barcelona, 08031, Spain
-
Hospital de la Santa Creu i Sant Pau
RECRUITINGBarcelona, Barcelona, 08031, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- Seaweed extract may tackle fatty liver Disease—A trial puts it to the test
- Can Weight-Loss surgery rewire the Liver's energy engine?
- Wheat sensitivity linked to fatty liver? a new study investigates
- Could a common sugar fuel liver damage?
- Could a common b vitamin tame fatty liver?